Document is current
Any future updates will be listed below
-
Authors
Sarto, Jordi
Esteller-Gauxax, Diana
Tort-Merino, Adrià
Guillén, Núria
Pérez-Millan, Agnès
Falgàs, Neus
Borrego-Écija, Sergi
Fernández-Villullas, Guadalupe
Bosch, Beatriz
Juncà-Parella, Jordi
Antonell, Anna
Naranjo, Laura
Ruiz-García, Raquel
Augé, Josep María
Sánchez-Valle, Raquel
Lladó, Albert
Balasa, Mircea https://orcid.org/0000-0002-1795-4228
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (19/00198, 19/00449, 20/00448, JR22/00014)
Emili Letang-Josep Font Hospital Clínic grant (2022)
Alzheimer's Association (AACSF-21-723056)
Global Brain Health Institute (GBHI ALZ UK-21-723831)
Joan Rodés-Josep Baselga-FBBVA (2022)
- License Information
-
More Information
Article History
Received: 22 October 2023
Revised: 5 December 2023
Accepted: 7 December 2023
First Online: 27 December 2023
Declarations
:
: RSV has served in Advisory boards Meetings for Wave Life Sciences, Ionis, UCB, Prevail, Pfizer and Novo Nordisk and received personal fees for participating in educational activities from Roche Diagnostics and Neuraxpharm. The other authors declare no conflict of interest.
: All participants gave written informed consent for participation in the study. The study protocol was approved by the Hospital Clínic de Barcelona Research Ethics Committee (HCB/2019/0600).
